Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

Click here to learn how you can benefit from its widespread distribution.

KYMR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.82%

Insider Buying (Last 12 Months): $2,518,965.84

Insider Selling (Last 12 Months): $39,524,544.03

Kymera Therapeutics Insider Trading History Chart

Kymera Therapeutics Share Price & Price History

^$48.48

▲ +2.4 (5.21%)

As of 09/16/2024 01:00 AM ET

Days: 30 | 90 | 365

Central Bank Abandons USD

From True Gold Republic | Ad

Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold.

Click here now to get your free 'Protect Your Wealth' Guide.

Kymera Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/26/2024	Jeffrey W. Albers	Director	Sell	5,000	$49.10	$245,500.00
7/16/2024	Jared Gollob	Insider	Sell	23,145	$45.81	$1,060,272.45	95,470
7/9/2024	Bruce Booth	Director	Sell	453,960	$38.21	$17,345,811.60	723,246
6/12/2024	Bruce Booth	Director	Sell	16,740	$35.45	$593,433.00	803,792
6/7/2024	Joanna Horobin	Director	Sell	8,500	$32.99	$280,415.00
3/15/2024	Bruce Booth	Director	Sell	71,764	$40.46	$2,903,571.44	806,697
3/13/2024	Bruce Booth	Director	Sell	139,255	$42.23	$5,880,738.65	828,830
3/13/2024	Venture Fund X L.P. Atlas	Major Shareholder	Sell	115,090	$42.23	$4,860,250.70	4,676,075
3/11/2024	Bruce Booth	Director	Sell	51,184	$42.85	$2,193,234.40	881,266
3/11/2024	Venture Fund X L.P. Atlas	Major Shareholder	Sell	42,302	$42.85	$1,812,640.70	4,925,812
3/4/2024	Bruce N. Jacobs	CFO	Sell	3,934	$41.86	$164,677.24	142,351
2/21/2024	Jeffrey W. Albers	Director	Sell	4,385	$39.05	$171,234.25
2/9/2024	Jared Gollob	Insider	Sell	46,137	$35.50	$1,637,863.50	74,709
1/23/2024	Jeffrey W. Albers	Director	Sell	10,000	$30.05	$300,500.00
1/4/2024	Ellen Chiniara	Insider	Sell	3,295	$22.58	$74,401.10	34,205
11/2/2023	Bvf Partners L P/Il	Director	Buy	216,406	$11.64	$2,518,965.84	2,552,306
3/2/2023	Bruce N. Jacobs	CFO	Sell	1,370	$31.00	$42,470.00	104,568
1/11/2023	Bvf Partners L P/Il	Director	Buy	22,110	$29.89	$660,867.90	2,491,703
1/11/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	21,683	$29.96	$649,622.68	5,045,242
12/14/2022	Bruce Booth	Director	Sell	378,966	$31.37	$11,888,163.42	918,528
12/14/2022	Venture Fund X L.P. Atlas	Major Shareholder	Sell	296,077	$31.37	$9,287,935.49	5,069,486
11/2/2022	Bruce Booth	Director	Sell	123,619	$30.02	$3,711,042.38	1,022,502
11/2/2022	Venture Fund X L.P. Atlas	Major Shareholder	Sell	96,581	$30.02	$2,899,361.62	5,440,875
10/31/2022	Bruce Booth	Director	Sell	120,622	$30.23	$3,646,403.06	1,066,388
10/31/2022	Venture Fund X L.P. Atlas	Major Shareholder	Sell	94,239	$30.23	$2,848,844.97	5,597,638
10/28/2022	Bruce Booth	Director	Sell	91,050	$30.00	$2,731,500.00	1,092,771
10/28/2022	Venture Fund X L.P. Atlas	Major Shareholder	Sell	71,135	$30.00	$2,134,050.00	5,691,877
8/22/2022	Bvf Partners L P/Il	Director	Buy	545,525	$26.00	$14,183,650.00	2,480,742
5/26/2022	Bvf Partners L P/Il	Director	Buy	224,057	$14.21	$3,183,849.97	2,159,903
5/20/2022	Bvf Partners L P/Il	Director	Buy	10,100	$14.00	$141,400.00	2,036,860
5/5/2022	Bvf Partners L P/Il	Director	Buy	150,000	$19.60	$2,940,000.00	1,975,767
1/31/2022	Bvf Partners L P/Il	Director	Buy	34,408	$40.70	$1,400,405.60
1/27/2022	Bvf Partners L P/Il	Director	Buy	95,901	$38.33	$3,675,885.33
1/24/2022	Bvf Partners L P/Il	Director	Buy	272,767	$37.76	$10,299,681.92
1/12/2022	Bruce N. Jacobs	CFO	Sell	15,000	$51.85	$777,750.00
1/12/2022	Nello Mainolfi	CEO	Sell	8,612	$52.08	$448,512.96
1/10/2022	Nello Mainolfi	CEO	Sell	22,465	$53.26	$1,196,485.90
12/3/2021	Bruce N. Jacobs	CFO	Sell	10,000	$53.56	$535,600.00
11/2/2021	Jared Gollob	Insider	Sell	14,996	$63.22	$948,047.12
10/11/2021	Nello Mainolfi	CEO	Sell	6,456	$53.68	$346,558.08
10/8/2021	Nello Mainolfi	CEO	Sell	41,544	$56.76	$2,358,037.44

My big AI project…

From Brownstone Research | Ad

On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.

Just click here to register.

SEC Filings (Institutional Ownership Changes) for Kymera Therapeutics (NASDAQ:KYMR)

Institutional Buying and Selling by Quarter

Kymera Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/16/2024	Algert Global LLC	32,706	$0.98M	0.0%	+16.5%	0.053%
8/16/2024	Driehaus Capital Management LLC	223,413	$6.67M	0.1%	N/A	0.364%
8/15/2024	Susquehanna Portfolio Strategies LLC	14,476	$0.43M	0.0%	-20.4%	0.024%
8/15/2024	Susquehanna Fundamental Investments LLC	76,818	$2.29M	0.1%	+7.4%	0.125%
8/15/2024	The Manufacturers Life Insurance Company	130,077	$3.88M	0.0%	+13.3%	0.212%
8/14/2024	Squarepoint Ops LLC	108,563	$3.24M	0.0%	+27.3%	0.177%
8/14/2024	Marshall Wace LLP	376,562	$11.24M	0.0%	-34.3%	0.614%
8/14/2024	ProShare Advisors LLC	9,250	$0.28M	0.0%	-20.3%	0.015%
8/14/2024	Profund Advisors LLC	17,011	$0.51M	0.0%	-48.2%	0.028%
8/13/2024	Public Employees Retirement Association of Colorado	4,672	$0.14M	0.0%	N/A	0.008%
8/12/2024	XTX Topco Ltd	6,748	$0.20M	0.0%	N/A	0.011%
8/12/2024	Hsbc Holdings PLC	18,182	$0.55M	0.0%	+81.0%	0.030%
8/12/2024	E Fund Management Co. Ltd.	48,946	$1.46M	0.1%	+391.2%	0.080%
8/9/2024	Renaissance Technologies LLC	143,093	$4.27M	0.0%	N/A	0.233%
8/9/2024	Dimensional Fund Advisors LP	402,385	$12.01M	0.0%	+15.2%	0.656%
8/9/2024	Massachusetts Financial Services Co. MA	405,870	$12.12M	0.0%	+2.7%	0.661%
8/9/2024	Atlas Venture Life Science Advisors LLC	5,350,422	$159.71M	16.8%	-0.5%	8.720%
8/8/2024	American Century Companies Inc.	10,847	$0.32M	0.0%	-77.2%	0.018%
8/6/2024	Quest Partners LLC	5,212	$0.16M	0.0%	+1,402.0%	0.008%
8/6/2024	Candriam S.C.A.	238,165	$7.11M	0.0%	-27.5%	0.388%
8/5/2024	Arizona State Retirement System	12,830	$0.38M	0.0%	+15.6%	0.021%
8/1/2024	Rhumbline Advisers	64,535	$1.93M	0.0%	+12.4%	0.105%
7/29/2024	Principal Financial Group Inc.	8,190	$0.24M	0.0%	-32.3%	0.013%
7/26/2024	Bank of New York Mellon Corp	156,211	$4.66M	0.0%	+19.3%	0.255%
7/17/2024	Keudell Morrison Wealth Management	7,105	$0.21M	0.1%	+7.2%	0.012%
7/12/2024	SG Americas Securities LLC	10,887	$0.33M	0.0%	+175.4%	0.018%
7/9/2024	Harbor Capital Advisors Inc.	31,011	$0.93M	0.1%	-25.0%	0.051%
6/4/2024	DekaBank Deutsche Girozentrale	23,562	$0.95M	0.0%	+7.1%	0.038%
5/20/2024	Virtu Financial LLC	5,147	$0.21M	0.0%	N/A	0.008%
5/17/2024	Artal Group S.A.	3,027,135	$121.69M	3.1%	+19.6%	4.933%
5/17/2024	Comerica Bank	3,324	$0.13M	0.0%	+13.7%	0.005%
5/16/2024	California State Teachers Retirement System	40,423	$1.63M	0.0%	+5.5%	0.066%
5/16/2024	Bayesian Capital Management LP	14,150	$0.57M	0.1%	N/A	0.023%
5/16/2024	Redmile Group LLC	1,734,089	$69.71M	2.6%	-4.9%	2.826%
5/15/2024	Price T Rowe Associates Inc. MD	6,332,012	$254.55M	0.0%	+18.7%	10.319%
5/15/2024	Avoro Capital Advisors LLC	3,888,888	$156.33M	1.8%	+3.0%	6.338%
5/14/2024	Nan Fung Group Holdings Ltd	10,875	$0.44M	0.4%	N/A	0.018%
5/14/2024	Natixis	1,979	$80K	0.0%	-50.2%	0.003%
5/14/2024	American International Group Inc.	20,095	$0.81M	0.0%	+6.4%	0.033%
5/13/2024	Seven Eight Capital LP	15,963	$0.64M	0.1%	-28.8%	0.026%
5/13/2024	Ameritas Investment Partners Inc.	4,070	$0.16M	0.0%	+7.8%	0.007%
5/10/2024	Vanguard Group Inc.	4,767,050	$191.64M	0.0%	+19.2%	7.769%
5/9/2024	State Board of Administration of Florida Retirement System	12,645	$0.51M	0.0%	+15.7%	0.021%
5/8/2024	ProShare Advisors LLC	11,609	$0.47M	0.0%	+18.0%	0.019%
5/8/2024	Russell Investments Group Ltd.	51,757	$2.08M	0.0%	+5.4%	0.084%
5/7/2024	Keudell Morrison Wealth Management	6,625	$0.27M	0.1%	N/A	0.011%
5/7/2024	Susquehanna Fundamental Investments LLC	71,493	$2.87M	0.1%	N/A	0.117%
5/7/2024	Swiss National Bank	79,700	$3.20M	0.0%	+12.3%	0.130%
5/7/2024	Nvwm LLC	7,304	$0.29M	0.1%	N/A	0.012%
5/7/2024	SG Americas Securities LLC	3,953	$0.16M	0.0%	-78.7%	0.006%
5/6/2024	Atlas Venture Life Science Advisors LLC	5,377,362	$216.17M	19.9%	-8.2%	8.764%
5/3/2024	GSA Capital Partners LLP	11,645	$0.47M	0.0%	-48.4%	0.019%
5/2/2024	Jennison Associates LLC	425,920	$17.12M	0.0%	N/A	0.694%
5/2/2024	FORA Capital LLC	20,343	$0.82M	0.1%	N/A	0.033%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	24,471	$0.98M	0.0%	+6.7%	0.040%
4/29/2024	Principal Financial Group Inc.	12,098	$0.49M	0.0%	+4.7%	0.020%
4/29/2024	China Universal Asset Management Co. Ltd.	11,753	$0.47M	0.1%	+83.0%	0.019%
4/11/2024	Congress Asset Management Co. MA	45,836	$1.84M	0.0%	+1.2%	0.075%
4/5/2024	Los Angeles Capital Management LLC	5,911	$0.24M	0.0%	-38.7%	0.010%
3/11/2024	Vanguard Group Inc.	3,997,564	$101.78M	0.0%	+1.8%	6.542%
3/5/2024	Wellington Management Group LLP	4,815,558	$122.60M	0.0%	-0.2%	8.117%
3/1/2024	Goldman Sachs Group Inc.	674,655	$17.18M	0.0%	+229.6%	1.137%
2/16/2024	Price T Rowe Associates Inc. MD	5,335,712	$135.85M	0.0%	+5.5%	9.616%
2/15/2024	BVF Inc. IL	5,161,801	$131.42M	3.3%	+8.9%	9.303%
2/14/2024	Avoro Capital Advisors LLC	3,775,000	$96.11M	1.3%	-2.1%	6.803%
2/14/2024	Seven Eight Capital LP	22,416	$0.57M	0.1%	N/A	0.040%
2/13/2024	Tower Research Capital LLC TRC	2,753	$70K	0.0%	-58.6%	0.005%
2/13/2024	Rafferty Asset Management LLC	120,189	$3.06M	0.0%	-19.9%	0.217%
2/13/2024	Campbell & CO Investment Adviser LLC	31,097	$0.79M	0.1%	N/A	0.056%
2/12/2024	TD Asset Management Inc	186,482	$4.75M	0.0%	+1.3%	0.336%
2/9/2024	Aigen Investment Management LP	9,162	$0.23M	0.0%	N/A	0.017%
2/9/2024	Quest Partners LLC	3,064	$78K	0.0%	N/A	0.006%
2/9/2024	Trexquant Investment LP	203,564	$5.18M	0.1%	N/A	0.367%
2/9/2024	UBS Group AG	300,463	$7.65M	0.0%	+84.6%	0.541%
2/9/2024	Norges Bank	504,083	$12.83M	0.0%	N/A	0.908%
2/8/2024	Massachusetts Financial Services Co. MA	462,675	$11.78M	0.0%	-0.2%	0.834%
2/7/2024	Teacher Retirement System of Texas	8,316	$0.21M	0.0%	-18.5%	0.015%
2/6/2024	Charles Schwab Investment Management Inc.	306,692	$7.81M	0.0%	+1.6%	0.553%
2/6/2024	Amalgamated Bank	5,424	$0.14M	0.0%	-6.8%	0.010%
2/6/2024	Los Angeles Capital Management LLC	9,648	$0.25M	0.0%	N/A	0.017%
2/6/2024	Swiss National Bank	71,000	$1.81M	0.0%	-10.2%	0.128%
2/5/2024	AtonRa Partners	16,808	$0.43M	0.9%	-12.3%	0.030%
2/5/2024	Russell Investments Group Ltd.	49,111	$1.25M	0.0%	+57.9%	0.089%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	22,940	$0.58M	0.0%	+2.3%	0.041%
1/24/2024	China Universal Asset Management Co. Ltd.	6,423	$0.16M	0.0%	+352.0%	0.012%
1/18/2024	Clear Harbor Asset Management LLC	10,000	$0.26M	0.0%	N/A	0.018%
1/12/2024	SG Americas Securities LLC	18,563	$0.47M	0.0%	N/A	0.033%
1/5/2024	Exchange Traded Concepts LLC	7,359	$0.19M	0.0%	+34.0%	0.013%
12/19/2023	Public Employees Retirement System of Ohio	8,301	$0.12M	0.0%	-62.1%	0.015%
12/18/2023	Vanguard Group Inc.	3,925,213	$54.56M	0.0%	+4.9%	7.074%
12/1/2023	Wellington Management Group LLP	4,823,329	$67.04M	0.0%	+0.0%	8.692%
11/15/2023	GSA Capital Partners LLP	51,088	$0.71M	0.1%	+141.2%	0.092%
11/15/2023	Rock Springs Capital Management LP	1,504,351	$20.91M	0.6%	+1.1%	2.711%
11/14/2023	Profund Advisors LLC	25,454	$0.35M	0.0%	-34.4%	0.046%
11/13/2023	Algert Global LLC	128,532	$1.79M	0.1%	+130.6%	0.232%
11/13/2023	Dark Forest Capital Management LP	36,698	$0.51M	0.0%	+89.0%	0.066%
11/13/2023	Hsbc Holdings PLC	13,244	$0.19M	0.0%	N/A	0.024%
11/13/2023	FMR LLC	870,547	$12.10M	0.0%	+3.9%	1.569%
11/13/2023	Rafferty Asset Management LLC	150,099	$2.09M	0.0%	-30.0%	0.270%
11/9/2023	Citigroup Inc.	100,796	$1.40M	0.0%	-7.2%	0.182%

Data available starting January 2016

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company develops STAT6, a Type 2 inflammation in allergic diseases; and TYK2, a treatment for inflammatory bowel disease, psoriasis, psoriatic arthritis, and lupus. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $48.48

$46.00

$49.08

50 Day Range

MA: $44.57

$36.25

$49.75

52 Week Range

Now: $48.48

$9.60

$50.19

Volume

429,407 shs

Average Volume

628,791 shs

Market Capitalization

$2.97 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.22

Who are the company insiders with the largest holdings of Kymera Therapeutics?: Kymera Therapeutics' top insider shareholders include:
Venture Fund X LP Atlas (Major Shareholder)
Bvf Partners L P/Il (Director)
Bruce Booth (Director)
Bruce N Jacobs (CFO)
Jared Gollob (Insider)
Ellen Chiniara (Insider)
Jeffrey W Albers (Director)
Joanna Horobin (Director)
Learn More about top insider investors at Kymera Therapeutics.
Who are the major institutional investors of Kymera Therapeutics?: Kymera Therapeutics' top institutional shareholders include:
Atlas Venture Life Science Advisors LLC — 8.72%
Massachusetts Financial Services Co. MA — 0.66%
Dimensional Fund Advisors LP — 0.66%
Marshall Wace LLP — 0.61%
Candriam S.C.A. — 0.39%
Driehaus Capital Management LLC — 0.36%
Learn More about top institutional investors of Kymera Therapeutics stock.
Which major investors are selling Kymera Therapeutics stock?: During the previous quarter, KYMR stock was sold by these institutional investors:
Marshall Wace LLP
Candriam S.C.A.
American Century Companies Inc.
Atlas Venture Life Science Advisors LLC
Profund Advisors LLC
Harbor Capital Advisors Inc.
Principal Financial Group Inc.
Susquehanna Portfolio Strategies LLC
Within the previous year, company insiders that have sold Kymera Therapeutics company stock include:
Venture Fund X LP Atlas (Major Shareholder)
Bvf Partners L P/Il (Director)
Bruce Booth (Director)
Bruce N Jacobs (CFO)
Jared Gollob (Insider)
Ellen Chiniara (Insider)
Jeffrey W Albers (Director)
Learn More investors selling Kymera Therapeutics stock.
Which major investors are buying Kymera Therapeutics stock?: In the previous quarter, KYMR stock was purchased by institutional investors including:
Driehaus Capital Management LLC
Renaissance Technologies LLC
Dimensional Fund Advisors LP
E Fund Management Co. Ltd.
Bank of New York Mellon Corp
Squarepoint Ops LLC
The Manufacturers Life Insurance Company
Massachusetts Financial Services Co. MA

War on Elon Escalates…

From Porter & Company | Ad